Risk factors for unprovoked epileptic seizures in multiple sclerosis: a systematic review and meta-analysis
- 867 Downloads
The role of different factors in influencing the risk of seizures during multiple sclerosis (MS) is not known. To perform a systematic review and meta-analysis of risk factors for epilepsy during MS. Pubmed, Google scholar, and Scopus databases were searched. Articles published in English (1986–2016) were included. Nine studies were included (3 retrospective cohort and 6 case–control) enrolling 2845 MS patients (217 with epilepsy; 7.6%). MS patients with epilepsy had a younger age at onset compared to MS patients without seizures (difference in means = −5.42 years, 95% CI −7.19 to −3.66, p < 0.001). Mean EDSS value at inclusion tended to be higher in patients with epilepsy, without reaching statistical significance (difference in means = 0.45, 95% CI −0.01 to 0.91, p = 0.054). No differences were observed in sex distribution (OR = 0.94, 95% CI 0.51–1.72, p = 0.83) and clinical form (OR = 1.03, 95% CI 0.33–3.21, p = 0.96). Two studies evaluated presence and number of cortical lesions as a risk factor for epilepsy in MS using different MRI techniques: in one study, cortical lesions were more frequently observed in patients with epilepsy (OR = 7.06, 95% CI 2.39–20.8; p < 0.001). In the other, cortico-juxtacortical lesions were more frequently observed in patients with epilepsy (OR = 2.6, 95% CI 1.0–6.5; p = 0.047). Studies about risk factors for epilepsy during MS are heterogeneous. Compared to MS patients without seizures, patients with epilepsy have an earlier MS onset and a higher EDSS score after similar disease duration. Clinical form of MS and sex do not predict the appearance of seizures.
KeywordsMultiple sclerosis Epilepsy Meta-analysis Age Cortical lesion
Compliance with ethical standards
Conflict of interest
Dr. Beghi reports grants from Italian Ministry of Health, during the conduct of the study; personal fees from Viropharma, grants from UCB-Pharma, grants from Italian Drug Agency (AIFA), personal fees from Viropharma, grants from Italian Ministry of Health, grants from EISAI, grants from American ALS Association, grants from Borgonovo Foundation, outside the submitted work. All other authors have no conflict of interest to declare.
- 23.Renoux C, Vukusic S, Mikaeloff Y, Edan G, Clanet M, Dubois B, Debouverie M, Brochet B, Lebrun-Frenay C, Pelletier J, Moreau T, Lubetzki C, Vermersch P, Roullet E, Magy L, Tardieu M, Suissa S, Confavreux C; Adult Neurology Departments KIDMUS Study Group (2007) Natural history of multiple sclerosis with childhood onset. N Engl J Med 356:2603–2613Google Scholar
- 27.Calabrese M, Castellaro M, Bertoldo A, De Luca A, Pizzini FB, Ricciardi GK, Pitteri M, Zimatore S, Magliozzi R, Benedetti MD, Manganotti P, Montemezzi S, Reynolds R, Gajofatto A, Monaco S (2016) Epilepsy in multiple sclerosis: the role of temporal lobe damage. Mult Scler (epub ahead of print) Google Scholar